OBJECTIVE: To evaluate directional diffusivities within the optic nerve in a first event of acute optic neuritis to determine whether decreased axial diffusivity (AD) would predict 6-month visual outcome and optic nerve integrity measures. DESIGN: Cohort study. SETTING: Academic multiple sclerosis center. Patients Referred sample of 25 individuals who presented within 31 days after acute visual symptoms consistent with optic neuritis. Visits were scheduled at baseline, 2 weeks, and 1, 3, 6, and 12 months. MAIN OUTCOME MEASURES: Visual acuity, contrast sensitivity, visual evoked potentials (VEPs), and thickness of the retinal nerve fiber layer (RNFL). RESULTS: An incomplete 6-month visual recovery was associated with a lower baseline AD (1.50 μm(2)/ms [95% confidence interval {CI}, 1.36-1.64 μm(2)/ms for incomplete recovery vs 1.75 μm(2)/ms [95% CI, 1.67-1.83 μm(2)/ms] for complete recovery). Odds of complete recovery decreased by 53% (95% CI, 27%-70%) for every 0.1-unit decrease in baseline AD. A lower baseline AD correlated with worse 6-month visual outcomes in visual acuity (r = 0.40, P = .03), contrast sensitivity (r = 0.41, P = .02), VEP amplitude (r = 0.55, P < .01), VEP latency (r = -0.38, P = .04), and RNFL thickness (r = 0.53, P = .02). Radial diffusivity increased between months 1 and 3 to become higher in those with incomplete recovery at 12 months than in those with complete recovery (1.45 μm(2)/ms [95% CI, 1.31-1.59 μm(2)/ms] vs 1.19 μm(2)/ms [95% CI, 1.10-1.28 μm(2)/ms]). CONCLUSIONS: Decreased AD in acute optic neuritis was associated with a worse 6-month visual outcome and correlated with VEP and RNFL measures of axon and myelin injury. Axial diffusivity may serve as a marker of axon injury in acute white matter injury.
OBJECTIVE: To evaluate directional diffusivities within the optic nerve in a first event of acute optic neuritis to determine whether decreased axial diffusivity (AD) would predict 6-month visual outcome and optic nerve integrity measures. DESIGN: Cohort study. SETTING:Academic multiple sclerosis center. Patients Referred sample of 25 individuals who presented within 31 days after acute visual symptoms consistent with optic neuritis. Visits were scheduled at baseline, 2 weeks, and 1, 3, 6, and 12 months. MAIN OUTCOME MEASURES: Visual acuity, contrast sensitivity, visual evoked potentials (VEPs), and thickness of the retinal nerve fiber layer (RNFL). RESULTS: An incomplete 6-month visual recovery was associated with a lower baseline AD (1.50 μm(2)/ms [95% confidence interval {CI}, 1.36-1.64 μm(2)/ms for incomplete recovery vs 1.75 μm(2)/ms [95% CI, 1.67-1.83 μm(2)/ms] for complete recovery). Odds of complete recovery decreased by 53% (95% CI, 27%-70%) for every 0.1-unit decrease in baseline AD. A lower baseline AD correlated with worse 6-month visual outcomes in visual acuity (r = 0.40, P = .03), contrast sensitivity (r = 0.41, P = .02), VEP amplitude (r = 0.55, P < .01), VEP latency (r = -0.38, P = .04), and RNFL thickness (r = 0.53, P = .02). Radial diffusivity increased between months 1 and 3 to become higher in those with incomplete recovery at 12 months than in those with complete recovery (1.45 μm(2)/ms [95% CI, 1.31-1.59 μm(2)/ms] vs 1.19 μm(2)/ms [95% CI, 1.10-1.28 μm(2)/ms]). CONCLUSIONS: Decreased AD in acute optic neuritis was associated with a worse 6-month visual outcome and correlated with VEP and RNFL measures of axon and myelin injury. Axial diffusivity may serve as a marker of axon injury in acute white matter injury.
Authors: Mingqiang Xie; Jennifer E Tobin; Matthew D Budde; Chin-I Chen; Kathryn Trinkaus; Anne H Cross; Dennis P McDaniel; Sheng-Kwei Song; Regina C Armstrong Journal: J Neuropathol Exp Neurol Date: 2010-07 Impact factor: 3.685
Authors: E Bergers; J C J Bot; C J A De Groot; C H Polman; G J Lycklama à Nijeholt; J A Castelijns; P van der Valk; F Barkhof Journal: Neurology Date: 2002-12-10 Impact factor: 9.910
Authors: Eric C Klawiter; Robert E Schmidt; Kathryn Trinkaus; Hsiao-Fang Liang; Matthew D Budde; Robert T Naismith; Sheng-Kwei Song; Anne H Cross; Tammie L Benzinger Journal: Neuroimage Date: 2011-01-13 Impact factor: 6.556
Authors: A Castriota-Scanderbeg; U Sabatini; F Fasano; R Floris; L Fraracci; M Di Mario; U Nocentini; C Caltagirone Journal: Neuroradiology Date: 2002-06-13 Impact factor: 2.804
Authors: Frederik Barkhof; Wolfgang Bruck; Corline J A De Groot; Elisabeth Bergers; Sandra Hulshof; Jeroen Geurts; Chris H Polman; Paul van der Valk Journal: Arch Neurol Date: 2003-08
Authors: Robert T Naismith; Junqian Xu; Eric C Klawiter; Samantha Lancia; Nhial T Tutlam; Joanne M Wagner; Peiqing Qian; Kathryn Trinkaus; Sheng-Kwei Song; Anne H Cross Journal: Neurology Date: 2013-05-10 Impact factor: 9.910
Authors: Emily T Wood; Itamar Ronen; Aranee Techawiboonwong; Craig K Jones; Peter B Barker; Peter Calabresi; Daniel Harrison; Daniel S Reich Journal: J Neurosci Date: 2012-05-09 Impact factor: 6.167
Authors: Steven L Galetta; Pablo Villoslada; Netta Levin; Kenneth Shindler; Hiroshi Ishikawa; Edward Parr; Diego Cadavid; Laura J Balcer Journal: Neurol Neuroimmunol Neuroinflamm Date: 2015-07-23